- ¥309bn
- ¥327bn
- ¥150bn
- 94
- 41
- 94
- 91
Annual income statement for Organo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 96,515 | 100,638 | 112,069 | 132,426 | 150,356 |
Cost of Revenue | |||||
Gross Profit | 27,283 | 26,327 | 28,513 | 34,977 | 43,842 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 86,695 | 91,285 | 101,334 | 117,243 | 127,809 |
Operating Profit | 9,820 | 9,353 | 10,735 | 15,183 | 22,547 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9,850 | 9,695 | 12,696 | 16,035 | 23,633 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7,172 | 7,087 | 9,226 | 11,765 | 17,335 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7,162 | 7,075 | 9,211 | 11,731 | 17,311 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7,162 | 7,074 | 9,210 | 11,730 | 17,310 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 158 | 158 | 184 | 256 | 377 |
Dividends per Share |